OBIO

Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) is a biomedical innovation company founded in 2020 and based in New Hope, Pennsylvania. The company went public on August 4, 2020, and operates as a development-stage biotechnology firm focused on creating medical devices and therapies for cardiovascular and other critical health conditions. Orchestra BioMed has established strategic partnerships with major medical device companies including Medtronic and Terumo Corporation to advance its product pipeline through clinical development and eventual commercialization.